Reaching a clinic is not the same as receiving enough care. Receiving enough appointments is not proof that the treatment fits. Even an appropriate pathway needs to measure what changed. Global mental-health evidence becomes more useful when these gaps remain separate. For families with extensive treatment options, purchasing access does not answer the final question about recovery.
Key findings
9.1%: modeled global coverage of minimally adequate treatment among people with major depressive disorder in 2021.
27.0% versus 2.0%: corresponding estimates in high-income locations and sub-Saharan Africa. Geographic income classifications are not personal wealth groups. [1]
47.1%: cases meeting stricter structural care criteria among cases already receiving minimally adequate treatment in a separate 2026 analysis. Clinical recovery was not measured. [2]
150 million: additional people targeted for access to mental-health care by 2030 in a global declaration. That is a target, not an achieved result. [4]
The uncertainty belongs beside the coverage estimate
Points show model estimates; lines show 95% uncertainty intervals. The global estimate includes the geographic groups and is not an independent comparison population. Source: Santomauro and colleagues, published 2024. [1]
The model drew on 32 studies covering 31 countries to estimate 204 countries and territories. A mapped value does not mean an equivalent direct national survey occurred in every location.
Under its definition, minimally adequate treatment meant one month of medication with four doctor visits, or eight psychotherapy visits. That operational threshold helps measure coverage without proving recovery.
A second study looked inside the appointments
A February 24, 2026 paper examined 2,313 person-disorder cases among 1,119 people who received minimally adequate treatment. It used surveys conducted from 2001 to 2019. Of those cases, 47.1% met stricter effective-treatment-coverage criteria. [2]
The label referred to operational criteria involving treatment type, provider, medication control, and adherence. The researchers did not obtain clinical outcome data.
The result therefore does not mean fewer than half recovered. Nor can it be multiplied by the 9.1% estimate from another study. Different periods, people, and definitions prevent a single measured funnel.
Access, adequacy, and recovery need separate evidence
| Claim | Required measure | Still unanswered |
|---|---|---|
| More people reached | Distinct people, eligibility, and period | Whether suitable treatment followed |
| Adequate care delivered | Defined threshold and eligible population | Whether treatment fitted the needs |
| Guidelines followed | Relevant recommendations and actual delivery | Whether the patient improved |
| Patients recovered | Outcome, baseline, timing, and missing data | How much change the program caused |
A consultation creates an opportunity to assess and plan. A timetable records intended activity. Neither settles whether the care delivered was appropriate or effective for the person.
Families can ask what each component aims to achieve, why it was selected, and how it will be reviewed. The answer need not promise certainty, but should provide a rationale and a response when progress is insufficient.
The outcome is a life after treatment
A patient can value the experience while still struggling. Another can improve clinically while needing more support in a different area. A single number treated cannot describe those combinations.
For someone returning to professional responsibilities or international travel, relevant outcomes may include functioning, sleep, relationships, and personal goals alongside condition-specific symptoms.
Recovery should not automatically mean immediate full productivity. The patient may choose different responsibilities or require ongoing support while making meaningful progress.
Later reporting should also identify other treatment. Improvement after residential care may occur alongside psychotherapy, medication changes, or support from another provider. Crediting it entirely to the first program would obscure the actual pathway.
High-income locations are not HNW households
A country’s income classification cannot identify an individual’s wealth or treatment experience. People within the same country differ in needs, eligibility, resources, and preferences.
Financial resources can be relevant to a practical choice, including travel, time away from work, and continuing care. This analysis does not estimate those effects or claim affluent patients are more ill or less likely to recover.
A genuine HNW study needs an explicit financial definition and suitable recruitment. Executive status, national income, and household assets should not be treated as interchangeable.
System resources are necessary, but not a patient result
WHO’s Mental Health Atlas 2024 was released on September 2, 2025. Its accompanying reporting described a global median of thirteen mental-health workers per 100,000 people and government mental-health spending at a median 2% of health budgets. Country-reporting gaps affect interpretation. [3]
These describe systems, not the success of individual treatments. A workforce number cannot be compared directly with a private clinic’s satisfaction percentage.
That does not make resources irrelevant. It makes the useful question how investment connects with appropriate access and patient benefit.
New capacity should lead to better evaluation
Service channels, clinical teams, and rehabilitation facilities can expand access. Reporting their existence is worthwhile, but should not become a regional prevalence estimate or a claim that treatment abroad is necessarily better.
Common definitions could make international evidence more useful than a ranking of incompatible headlines. A service with detailed reporting should not look worse simply because another publishes less.
For families in the UK, the United States, Western Europe, or the Gulf, local context remains important. The right pathway depends on the person, not the country’s position in a system-level table.
A global target is not an achieved result
On December 16, 2025, WHO reported adoption of a global declaration addressing noncommunicable diseases and mental health. Its targets included 150 million more people accessing mental-health care by 2030. [4]
| Evidence | Release | What it represents |
|---|---|---|
| Depression-treatment model | 2024 | Estimated coverage in 2021 |
| Mental Health Atlas 2024 | September 2025 | System reporting, with gaps |
| Global declaration | December 2025 | A 2030 target |
| Quality-of-care analysis | February 2026 | Surveys from 2001 to 2019 |
A new publication may improve understanding of an older period. It does not make those observations current. A target can be newsworthy without proving a policy has already worked.
What families should request before comparing destinations
Begin with clinical suitability, then ask how the provider measures change and responds when care is not progressing as hoped. Distinguish evidence for individual treatment components from direct evaluation of the complete program.
Request the denominator: all admissions, completers, and follow-up respondents answer different questions. Missing outcomes should remain unknown rather than silently become successes or failures.
Where clinicians or countries change, ask who accepts the handover and what information is shared. Family or adviser support should not displace the patient or create unrestricted access to clinical information.
THE BALANCE should meet the same standard. This article does not supply a proprietary recovery percentage or an international-provider ranking.
The bottom line
More access matters, and so does the content of care. Neither removes the need to understand what happens over time. Wealth can expand options, but it cannot make an undefined outcome meaningful. A useful pathway explains its evidence, responsibilities, and limits.
For journalists
Key distinction: the 9.1% modeled coverage estimate and the separate 47.1% structural-quality result do not measure recovery or form a valid numerical funnel.
Important caveat: new publication dates do not imply newly collected data.
Suggested attribution: THE BALANCE analysis of published global treatment-coverage evidence.
Methodology and sources
This selective narrative analysis keeps modeled coverage, structural criteria, system resources, and targets separate. Published uncertainty intervals are reproduced without alteration. No original clinical dataset or pooled global recovery rate was created.
- Santomauro and colleagues. Major depressive disorder service coverage in 2021. Lancet Psychiatry, 2024. DOI 10.1016/S2215-0366(24)00317-1. Source licensed CC BY 3.0 IGO. Citation does not imply WHO endorsement of THE BALANCE.
- Kazdin and colleagues. Transition from minimally adequate treatment to effective coverage. February 24, 2026.
- WHO. Mental-health service reports. September 2, 2025.
- WHO. Global declaration on noncommunicable diseases and mental health. December 16, 2025.
